1E Therapeutics

1E Therapeutics is at the forefront of pharmaceutical manufacturing, dedicated to the development of innovative RNA-targeting drugs. As a clinical stage company, 1E Therapeutics is focused on creating first-in-class therapeutics using its proprietary drug design platform. This groundbreaking approach allows for the rapid development of innovative drugs that target chronic, life-threatening conditions, as well as emerging pathogens.

The company's proprietary drug design process has yielded lead compounds addressing a wide array of indications, including oncology, age-related diseases, anti-microbial resistance, and neurological disorders. 1E Therapeutics operates primarily out of its facility in Rehovot, IL, where cutting-edge research and development drive the company's mission to improve patient outcomes through novel therapeutic interventions.

With a strong foundation built on years of innovation and significant investment, 1E Therapeutics is poised to make a substantial impact on the pharmaceutical industry. We encourage the management team at 1E Therapeutics to take the next step in showcasing their expertise by creating a customized and exclusive company showcase and product listing on our platform.